Ebola Information

We are prepared to screen and isolate for Ebola patients should they come to us. Learn more.


Rheumatology Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects with Systemic Lupus Erythematosus.

  • Principal Investigator: Alla Rudinskaya, M.D.
  • Pharmaceutical Sponsor: Amgen, Inc.

 

A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects with Systemic Lupus Erythematosus.

  • Principal Investigator: Alla Rudinskaya, M.D.
  • Pharmaceutical Sponsor: Amgen, Inc.

 

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects with Systemic Lupus Erythematosus With and Without Glomerulonephritis.

  • Principal Investigator: Alla Rudinskaya, M.D.
  • Pharmaceutical Sponsor: Amgen, Inc.



close